VEGFA and Stroke: The current study is designed as a proof-of-principle to investigate the therapeutic efficacy of in vivo and ex vivo triple gene therapy (VEGF, GDNF, and NCAM) for increasing survivability of the affected neurons in a rat model of stroke.